Literature DB >> 20579547

Aspirin for primary prevention of cardiovascular events in people with diabetes.

Michael Pignone1, Mark J Alberts, John A Colwell, Mary Cushman, Silvio E Inzucchi, Debabrata Mukherjee, Robert S Rosenson, Craig D Williams, Peter W Wilson, M Sue Kirkman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20579547     DOI: 10.1016/j.jacc.2010.04.003

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  30 in total

1.  Statin adherence and the risk of major coronary events in patients with diabetes: a nested case-control study.

Authors:  Päivi Ruokoniemi; Maarit J Korhonen; Arja Helin-Salmivaara; Piia Lavikainen; Antti Jula; Seppo Y T Junnila; Raimo Kettunen; Risto Huupponen
Journal:  Br J Clin Pharmacol       Date:  2011-05       Impact factor: 4.335

2.  Hyperglycemia repression of miR-24 coordinately upregulates endothelial cell expression and secretion of von Willebrand factor.

Authors:  Yaozu Xiang; Jijun Cheng; Dandan Wang; Xiaoyue Hu; Yi Xie; Jeremiah Stitham; Gourg Atteya; Jing Du; Wai Ho Tang; Seung Hee Lee; Kristen Leslie; Geralyn Spollett; Zejian Liu; Erica Herzog; Raimund I Herzog; Jun Lu; Kathleen A Martin; John Hwa
Journal:  Blood       Date:  2015-03-26       Impact factor: 22.113

3.  Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America.

Authors:  Gregory M Lucas; Michael J Ross; Peter G Stock; Michael G Shlipak; Christina M Wyatt; Samir K Gupta; Mohamed G Atta; Kara K Wools-Kaloustian; Paul A Pham; Leslie A Bruggeman; Jeffrey L Lennox; Patricio E Ray; Robert C Kalayjian
Journal:  Clin Infect Dis       Date:  2014-09-17       Impact factor: 9.079

4.  Acetylsalicylic acid, but not clopidogrel, inhibits therapeutically induced cerebral arteriogenesis in the hypoperfused rat brain.

Authors:  André Duelsner; Nora Gatzke; Johanna Glaser; Philipp Hillmeister; Meijing Li; Eun-Ji Lee; Kerstin Lehmann; Daniel Urban; Heike Meyborg; Philipp Stawowy; Andreas Busjahn; Stephanie Nagorka; Anja Bondke Persson; Ivo R Buschmann
Journal:  J Cereb Blood Flow Metab       Date:  2011-08-10       Impact factor: 6.200

Review 5.  Primary thrombosis prophylaxis in antiphospholipid antibody-positive patients: where do we stand?

Authors:  Medha Barbhaiya; Doruk Erkan
Journal:  Curr Rheumatol Rep       Date:  2011-02       Impact factor: 4.592

6.  Do clinicians recommend aspirin to patients for primary prevention of cardiovascular disease?

Authors:  Kevin Fiscella; Paul C Winters; Michael Mendoza; Gary J Noronha; Carlos M Swanger; John D Bisognano; Robert J Fortuna
Journal:  J Gen Intern Med       Date:  2015-02       Impact factor: 5.128

Review 7.  Diabetes and sex: from pathophysiology to personalized medicine.

Authors:  Rosanna Abbate; Edoardo Mannucci; Gabriele Cioni; Cinzia Fatini; Rossella Marcucci
Journal:  Intern Emerg Med       Date:  2012-10       Impact factor: 3.397

8.  The Michigan Model for Coronary Heart Disease in Type 2 Diabetes: Development and Validation.

Authors:  Wen Ye; Michael Brandle; Morton B Brown; William H Herman
Journal:  Diabetes Technol Ther       Date:  2015-07-29       Impact factor: 6.118

Review 9.  Platelet function profiles in patients with diabetes mellitus.

Authors:  Fabiana Rollini; Francesco Franchi; Ana Muñiz-Lozano; Dominick J Angiolillo
Journal:  J Cardiovasc Transl Res       Date:  2013-02-13       Impact factor: 4.132

Review 10.  A meta-analysis of salicylates for type 2 diabetes mellitus.

Authors:  Fang Fang; Yu Lu; De-Lin Ma; Ting-Ting Du; Shi-Ying Shao; Xue-Feng Yu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-02-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.